VIVOZON PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 082800 for the last quarter is 23.63 B KRW, and it's 13.25% higher compared to the previous quarter. The net income of Q3 24 is 255.84 M KRW.